~ 5.2 million people in the U.S. have been EXPOSED to

or are INFECTED with HCV.1,2

Both the CDC and AASLD have issued new screening

guidelines in an effort to identify these HCV positive

people before it’s too late.3

OraQuick® HCV Rapid Antibody Test –

The only FDA-approved, point-of-care test for hepatitis C

(HCV) antibodies that meets the new guidelines.

• Accurate. Reliable results with >98% accuracy.

• Simple. 3-easy steps; CLIA-waived.

• Fast. Test and result delivery in 20 minutes forimmediate linkage to care.

Test it. Find it. Fight it. Today!

Up to 3 out of 4 People withHepatitis C Don’t Know

They’re Infected1,2

HCV0133 0615 OQ HCV Sales Sheet_Layout 1 7/6/15 8:16 AM Page 1

OraQuick® HCV Rapid Antibody TestLinking People to Care

Simple. 3-easy step procedure that requires less than 2 minutesof hands on time; CLIA-waived.

Accurate. Reliable results with >98% accuracy4

Fast. Test and result delivery in 20 minutes for immediate linkage to care.

Step 1Fingerstick sample. Touch the5μL loop to the blood droplet.

Step 2Mix blood-filled loop into vial.Remove and insert test device.

Step 3Read results between

20 and 40 minutes.

Non-reactive Reactive

Sample Type Positive % Agreement Negative % Agreement

Fingerstick 97.9%* (708 / 723) 98.5%* (923 / 937)

Venipuncture 99.5%* (435 / 437) 99.0%* (762 / 770)

Meets the new CDC and AASLD guidelines for hepatitis screening of all patients at risk. Theversatile testing platform is ideally suitable for both clinical and non-clinical settings.

1) Chak, et al. Hepatitis C Virus Infection in the USA: An Estimate of True Prevalence. Liver International 2011; Vol. 31:1090-1101. 2) CDC. Hepatitis C TestingBaby Boomers Saves Lives. CDC Vital Signs May 2013. 3) Moyer, Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task ForceRecommendation Statement, Annals of Internal Medicine, www.anals.org 06/25/2013. 4) OraQuick® HCV Rapid Antibody Test Package Insert.

Please refer to the package insert for complete information and instructions on the proper use of OraQuick® HCV Rapid Antibody test. ©2015, 2014 OraSureTechnologies, Inc. U.S. Patent #7,192,555 and various international and U.S. patents pending. OraQuick® is a registered trademarks of OraSure Technologies,Inc. Item#HCV0133 06/15

* Includes subjects with “unable to determine” status

220 East First StreetBethlehem, PA 18015 USAphone: 1.800.ORASUREweb: TestHepC.com • OraSure.com

Made in the USA

Order Information Description CPT Code1001-0181 Box of 25 tests 868031001-0180 Box of 100 tests Medicare 1001-0182 Controls HCPCS1001-0343 Visual Reference Panel G0472 HEP C TEST IT.

FIND IT.FIGHT IT.

HCV0133 0615 OQ HCV Sales Sheet_Layout 1 7/6/15 8:16 AM Page 2